Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Robert J Konrad

Effects of Currently Prescribed LDL-C-lowering Drugs on PCSK9 and Implications for the Next Generation of LDL-C-lowering Agents

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2011English

Related publications

Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors.

Cardiologia Croatica
Cardiovascular MedicineCardiology
2016English

Effects of Intensive LDL Lowering on Coronary Atherosclerosis

Cardiovascular Medicine
2017English

Beyond Lowering LDL Cholesterol

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2011English

Phenome-Wide Association Analysis of LDL-cholesterol Lowering Genetic Variants in PCSK9

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2019English

Evolving Concepts in LDL-Lowering Strategies: Are We There?

Journal of Clinical & Experimental Cardiology
2016English

Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Long-Term Benefits of LDL Cholesterol Lowering in Young Adulthood: A Computer Simulation Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Use of Antiepileptic Drugs and Lipid-Lowering Agents in the United States

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2014English

Lipid Lowering Therapy and Circulating PCSK9 Concentration

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy